Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 | 2026-07-29 | AH Bio Fund II, L.P. | 10% Owner | Purchase | 333.3K | $15.00 | $5.00M | 2.39M | View | |
| 2026-07-27 | 2026-07-29 | ORBIMED ADVISORS LLC | Director | Purchase | 1.00M | $15.00 | $15.00M | 1.35M | View | |
| 2026-07-27 | 2026-07-29 | GORDON CARL L | Director | Purchase | 1.00M | $15.00 | $15.00M | 1.35M | View | |
| 2026-07-28 | 2026-07-28 | Aghazadeh Behzad | Director | Purchase | 7,905 | $18.25 | $144K | 3.09M | View | |
| 2026-07-24 | 2026-07-28 | Aghazadeh Behzad | Director | Purchase | 2.38M | $15.15 | $36.12M | 3.08M | View |
Informational purposes only, not investment advice.
tormere.com/research/SCTX · generated 2026-10-28
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-27 | AH Bio Fund II, L.P. | P | 333,333 | $5M |
| 2026-07-27 | ORBIMED ADVISORS LLC | P | 1,000,000 | $15M |
| 2026-07-27 | GORDON CARL L | P | 1,000,000 | $15M |
| 2026-07-28 | Aghazadeh Behzad | P | 7,905 | $144,266.25 |
| 2026-07-24 | Aghazadeh Behzad | P | 50,000 | $1M |
Tormere — informational purposes only, not investment advice.